This webinar will provide insight from ShareAction's latest ‘Tracking for Health’ briefing. We will look at how retailers define and measure sales from healthier products, and will give an overview of the work the Healthy Markets investor…
Cellebrite, an Israeli surveillance tech company, is going public on Nasdaq this summer. Access Now have learned of egregious human rights abuses allegedly committed with the help of Cellebrite's technologies around the world. This open letter requires stakeholders to halt the deal unless Cellebrite
demonstrates human rights compliance.
Cellebrite reports that public perceptions that its products were being used in ways incompatible with human rights, “could adversely affect our reputation, revenue and results of operations.”
Cellebrite’s plan to go public poses a test for the SEC, stock exchanges, and investors as to whether they can deliver the sustainable financial system that responsible investors demand.
This open letter presents an opportunity to set a positive precedent for transparency and accountability for human rights violations and risks of publicly‐traded companies (especially in the technology sector), currently being addressed by the U.S. Senate.
Contact Hinako Sugiyama for more information.
Please join the collaboration to see more details on how you can get involved.